Company Filing History:
1 out of 174 
1 out of 433 
1 out of 34 
Years Active: 2004-2012
Title: Sumihare Noji: Innovator in Nucleic Acid Probes and Therapeutic Agents
Introduction
Sumihare Noji is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the fields of nucleic acid probes and therapeutic agents for cartilaginous diseases. With a total of 2 patents, his work has advanced the understanding and application of these technologies.
Latest Patents
Noji's latest patents include a novel nucleoside triphosphate derivative and a multilabeled nucleic acid probe. These innovations allow for the convenient and highly sensitive detection of target nucleic acids. His methods for producing these probes utilize transglutaminase (TGase) to enhance detection capabilities. Additionally, he has developed a therapeutic agent for cartilaginous diseases, which includes hepatocyte growth factor (HGF) as an active component. This agent promotes chondrocyte proliferation and proteoglycan production, offering potential treatments for various disorders related to cartilaginous diseases.
Career Highlights
Throughout his career, Noji has worked with notable organizations such as Sumitomo Pharmaceuticals Company Limited and Kyushu University. His experience in these institutions has contributed to his expertise in the development of innovative medical solutions.
Collaborations
Noji has collaborated with esteemed colleagues, including Masahiro Iwamoto and Toshikazu Nakamura. These partnerships have fostered a collaborative environment that enhances research and development in his field.
Conclusion
Sumihare Noji's contributions to nucleic acid technology and therapeutic agents highlight his role as an influential inventor. His work continues to impact the medical and scientific communities positively.